Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Independent prognostic implications of RRM2 in lung adenocarcinoma

1 Jan 2020

Abstract excerpt

Background: Ribonucleoside-diphosphate reductase subunit M2 (RRM2) is the catalytic subunit of ribonucleotide reductase and modulates the enzymatic activity, which is essential for DNA replication and repair. However, the role of RRM2 in lung adenocarcinoma (LUAD) remains unclear. Methods: In this study, we explored the expression pattern and prognostic value of RRM2 in LUAD across TCGA, GEO, Oncomine, UALCAN,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33123291
DOI: 10.7150/jca.47895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Independent prognostic implications of RRM2 in lung adenocarcinomaPMID 33123291Read ↗

A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumorsSemantic proximity Read ↗

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerSemantic proximity Read ↗

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinomaSemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancerSemantic proximity Read ↗

Over-expression of RRM2 Predicts Poor Prognosis in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on TCGA DataSemantic proximity Read ↗

E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinomaSemantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

Evaluation of Clinical Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma via BioinformaticsSemantic proximity Read ↗

Identification of RRM2 as Novel Potential Sero-Diagnostic Marker for Non-Small Cell Lung CancerSemantic proximity Read ↗

Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinomaSemantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.